Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02926235 · ClinicalTrials.gov registry record · Phase 4
Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02926235 is a Phase 4 study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 50 participants.
The verdict
NCT02926235, a Phase 4 study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this trial is to assess the efficacy of essential amino acids (EAA) on muscle atrophy and malnutrition compared to a placebo in patients following a total knee arthroplasty. The investigators specific objectives included analysis of (1) muscle strength, (2) change in malnutrition, (3) perioperative complications (4) physical activity.
Interventions
- OTHER Placebo
- DRUG Amino Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-05-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02926235
The ClinicalTrials.gov registry entry for NCT02926235 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02926235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02926235 about?
NCT02926235 is a clinical study titled "Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty". The goal of this trial is to assess the efficacy of essential amino acids (EAA) on muscle atrophy and malnutrition compared to a placebo in patients following a total knee arthroplasty. The investigators specific objectives included analysis of (1) muscle strength, (2) change in malnutrition, (3) pe...
What is the current status of trial NCT02926235?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2016-04. Estimated completion is 2022-05-14.
What interventions are being tested in trial NCT02926235?
The interventions under investigation include: Placebo (OTHER), Amino Acid (DRUG).
Who is sponsoring clinical trial NCT02926235?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.